Drug Profile
hA19-SN-38 antibody-drug conjugate - Immunomedics
Alternative Names: Anti-CD19 antibody-SN-38 antibody-drug conjugate - Immunomedics; hA19-SN-38 ADC - ImmunomedicsLatest Information Update: 28 Dec 2020
Price :
$50
*
At a glance
- Originator Immunomedics
- Class Immunoconjugates
- Mechanism of Action CD19 antigen modulators; DNA topoisomerase I inhibitors; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Haematological malignancies